ASSET PURCHASE AGREEMENT by and between Targent Inc. as Seller, certain stockholders of Seller, and Spectrum Pharmaceuticals, Inc. as Purchaser Dated as of March 17, 2006Asset Purchase Agreement • May 1st, 2006 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of the 17th day of March, 2006, by and between Targent Inc., a Delaware corporation, and any successor thereto (“Seller”), and Spectrum Pharmaceuticals, Inc., a Delaware corporation (“Purchaser”) and with respect to Article IX, the stockholders of Seller listed on Schedule A hereto (the “Stockholders”).
DEVELOPMENT AND MARKETING AGREEMENTDevelopment and Marketing Agreement • May 1st, 2006 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Development and Marketing Agreement (this “Agreement”) is hereby entered into and effective as of February 22, 2006 (the “Effective Date”) by and between Spectrum Pharmaceuticals, Inc. (“Spectrum”), a Delaware corporation, with offices located at 157 Technology Drive, Irvine, California 92618 and Par Pharmaceutical, Inc. (“Par”), a Delaware corporation with offices located at 300 Tice Boulevard, Woodcliff Lake, New Jersey 07677. Spectrum and Par shall each be defined as a “Party” and together as the “Parties” under this Agreement.
VOTING AGREEMENTVoting Agreement • May 1st, 2006 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This VOTING AGREEMENT (this “Agreement”) is entered into as of March 17, 2006, by and among Spectrum Pharmaceuticals, Inc., a Delaware corporation (“Acquiror”), and the stockholders of Targent Inc., a Delaware corporation (the “Company”) listed on Schedule A hereto (the “Stockholders”).
